ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q2SCImago #9,953HybridDomestic Journal

International Journal of Ophthalmology

Acronym:ijo
•
Abbreviation (ISO):INT J OPHTHALMOL-CHI
•
Identifier (ISSN):2222-3959(Print)/2227-4898(Online)
•
Publisher:IJO Press Co., Limited
Clarivate IF (2026)
2↑ +0.2
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2020–2026)

Clarivate IF trend for International Journal of Ophthalmology

WoS Q3
01231.3320201.7820211.6520221.420231.920241.8202522026
Annual Impact Factor Metric
Current (2026):2
Scopus SJR & RankScopus Q2
0.595
#9,953

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
53

53 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate26.3%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
256articles/year
99.5% Gold OA•90.08% Original Research

Aims & Scope

· International Journal of Ophthalmology-IJO (English edition) is a global ophthalmological scientific publication and a peer-reviewed open access periodical (ISSN 2222-3959 print, ISSN 2227-4898 online). This journal is sponsored by Chinese Medical Association Xi’an Branch and obtains guidance and support from WHO and ICO (International Council of Ophthalmology). It has been indexed in SCIE, PubMed, PubMed-Central, Chemical Abstracts, Scopus, EMBASE , and DOAJ. IJO JCR IF in 2017 is 1.166. IJO was established in 2008, with editorial office in Xi’an, China. It is a monthly publication. General Scientific Advisors include Prof. Hugh Taylor (President of ICO); Prof.Bruce Spivey (Immediate Past President of ICO); Prof.Mark Tso (Ex-Vice President of ICO) and Prof.Daiming Fan (Academician and Vice President, Chinese Academy of Engineering. International Scientific Advisors include Prof. Serge Resnikoff (WHO Senior Speciatist for Prevention of blindness), Prof. Chi-Chao Chan (National Eye Institute, USA) and Prof. Richard L Abbott (Ex-President of AAO/PAAO) et al. Honorary Editors-in-Chief: Prof. Li-Xin Xie(Academician of Chinese Academy of Engineering/Honorary President of Chinese Ophthalmological Society); Prof. Dennis Lam (President of APAO) and Prof. Xiao-Xin Li (Ex-President of Chinese Ophthalmological Society). Chief Editor: Prof. Xiu-Wen Hu (President of IJO Press). Editors-in-Chief: Prof. Yan-Nian Hui (Ex-Director, Eye Institute of Chinese PLA) and Prof. George Chiou (Founding chief editor of Journal of Ocular Pharmacology & Therapeutics). Associate Editors-in-Chief include: Prof. Ning-Li Wang (President Elect of APAO); Prof. Ke Yao (President of Chinese Ophthalmological Society) ; Prof.William Smiddy (Bascom Palmer Eye instituteUSA) ; Prof.Joel Schuman (President of Association of University Professors of Ophthalmology,USA); Prof.Yizhi Liu (Vice President of Chinese Ophtlalmology Society); Prof.Yu-Sheng Wang (Director of Eye Institute of Chinese PLA); Prof.Ling-Yun Cheng (Director of Ocular Pharmacology, Shiley Eye Center, USA). IJO accepts contributions in English from all over the world. It includes mainly original articles and review articles, both basic and clinical papers. Instruction is Welcome Contribution is Welcome Citation is Welcome Cooperation organization International Council of Ophthalmology(ICO), PubMed, PMC, American Academy of Ophthalmology, Asia-Pacific, Thomson Reuters, The Charlesworth Group, Crossref,Scopus,Publons, DOAJ etc.

Topics Covered (Recognized by AI)
Medicine99.7%Biology88.4%Ophthalmology81.7%Surgery64.9%Physics64.7%Optics59.5%Internal medicine57.2%Psychology55.6%Chemistry52.2%Biochemistry47.7%Genetics47.6%Neuroscience45.2%Pathology37.2%Visual acuity35.4%Botany27.8%Psychiatry27.4%Retinal24.3%Endocrinology23.2%Radiology22.5%Immunology21%Optometry20.4%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

OPHTHALMOLOGY

Q3
Rank55/98
IndexSCIE
JCISCIE2026

OPHTHALMOLOGY

Q3
Rank50/98
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF2
Articles / Year189
Total Citations14
2025
IF1.8
Articles / Year314
Total Citations244
2024
IF1.9
Articles / Year319
Total Citations876
2023
IF1.4
Articles / Year311
Total Citations1,573
2022
IF1.645
Articles / Year327
Total Citations2,134

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #9,953Scopus Q2SCImago Profile
Scopus Coverage:2005-2025
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q2
0.595

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
1.81

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,008 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,736
3-Year Documents938
Citable Documents810

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)2

Citations in government and international policy documents

Female Author Rate41.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

OphthalmologyQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 26.3%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
3区OPHTHALMOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

International Journal of Ophthalmology (acronym: ijo, abbr: INT J OPHTHALMOL-CHI, ISSN: 2222-3959) is a peer-reviewed international scholarly journal in the field of Medicine, published by IJO Press Co., Limited in China since 2008. The periodical holds a Journal Impact Factor (JIF) of 2.00, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.595 (Q2), an H-index of 53.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 256 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,008 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
IJO Press Co., Limited
Publication Language
English
Frequency
Monthly
Founding Year
2008
Indexing & Databases
SCIEScopusDOAJPubMed
Editorial Address
IJO PRESS, NO 269 YOUYI EAST RD, XI AN, PEOPLES R CHINA, 710054

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: bcb8acfd-0a51-4b8b-847d-a47e15e39f83
Database Updated: 2026-10-01